$\require{mediawiki-texvc}$
  • 검색어에 아래의 연산자를 사용하시면 더 정확한 검색결과를 얻을 수 있습니다.
  • 검색연산자
검색연산자 기능 검색시 예
() 우선순위가 가장 높은 연산자 예1) (나노 (기계 | machine))
공백 두 개의 검색어(식)을 모두 포함하고 있는 문서 검색 예1) (나노 기계)
예2) 나노 장영실
| 두 개의 검색어(식) 중 하나 이상 포함하고 있는 문서 검색 예1) (줄기세포 | 면역)
예2) 줄기세포 | 장영실
! NOT 이후에 있는 검색어가 포함된 문서는 제외 예1) (황금 !백금)
예2) !image
* 검색어의 *란에 0개 이상의 임의의 문자가 포함된 문서 검색 예) semi*
"" 따옴표 내의 구문과 완전히 일치하는 문서만 검색 예) "Transform and Quantization"
쳇봇 이모티콘
안녕하세요!
ScienceON 챗봇입니다.
궁금한 것은 저에게 물어봐주세요.

논문 상세정보

Anti-HBc 단독 양성자에서 B형 간염 백신 접종의 면역 반응과 B형 간염 DNA의 조사

A Study of Immune Response to Hepatitis B Vaccine & HBV DNA in Isolated Anti-HBc Positive Subjects

Abstract

Objectives: The aim of this study was to evaluate the response to a hepatitis B vaccination, and investigate the HBV DNA in subjects with isolated anti-HBc. Methods: 34 subjects with persistent isolated anti-HBc were included in the study. 32 subjects negative for HBsAg, anti-HBs and anti-HBc were included as a control group. They were all vaccinated with Hepaccine at 0, 1 and 2 months, and anti-HBs titers were measured 1 month after the 1st and 3rd vaccinations (1 and 3 months). The HBV-DNA was tested by polymerase chain reaction in subjects with isolated anti-HBc. Results: After the 1st & 3rd vaccinations, the anti-HBs titers$\geq$10mIU/ml were 70.6 & 70.6% in isolated anti-HBc group, and 34.4 & 81.2% in the control group, respectively. There were statistically significant differences after the 1st vaccination, but none after the 3rd, between the two groups. In the isolated anti-HBc and control groups, the primary, amnestic and no responses were 0 vs. 46.9%, 55.9 vs. 6.3% and 29.4 vs. 18.8%, respectively. The HBV DNA was not detected in all subjects with isolated anti-HBc. Conclusion: None of the subjects with isolated anti-HBc had a false positive result (primary response); therefore, they should be excluded from vaccination programs in Korea. To differentiate between immunity and occult infections, a single dose of vaccine, with a follow-up anti-HBs test, is preferable for subjects with isolated anti-HBc. An amnestic response indicates late immunity, and no response a suspect occult infection.

참고문헌 (35)

  1. Deinhardt F. Serum markers of hepatitis B viruses in natural disease and after vaccination. Prog Liver Dis 1982; 7: 451-467 
  2. Chan HY, Lok AF. Hepatitis B in adults: A clinical perspective. Clin Liver Dis 1999; 3: 291-307 
  3. Grob P, Jilg W, Bomhak H, Gerken G, Gerken G, Gerlich W, Gunther S, Hess G, Hudig H. Kitchen A, Margolis H, Michel G, Trepo C, Will H, Zanetti A, Mushahwar I. Serological pattern 'Anti-HBc Alone': Report on a workshop. J Med Virol. 2000; 62(4): 450-455 
  4. Douglas DD, Taswell HF', Rakela J, Rabe D. Absence of hepatitis B virus DNA detected by polymerase chain reaction in blood donors who are hepatitis B surface antigen negative and antibody to hepatitis B core antigen positive from a United States population with a low prevalence of hepatitis B serologic markers. Transfusion 1993; 33: 212-216 
  5. Bart PA, Jacquier P, Zuber PLF, Lavanchy D, Frei PC. Seroprevalence of HBV (anti-HBc, HBsAg and anti-HBs) and HDV infections among 9006. women at delivery Liver 1996; 16: 110-116 
  6. Hu M, Schenzle D, Deinhardt F, Scheid R. Epidemiology of hepatitis A and B in the shanghai area: prevalence of serum markers, Am J Epidemiol; J 1984; 120: 404-413 
  7. Feret E, Larauze B, Diop E, Sow M, London WT, Blumberg BS, Epidemiology of hepatitis B virus infection in the rural community of tip. Senegal Am J Epidemiol 1987; 125 :140-149 
  8. Lok ASF, Lai CL, Wu PC: Prevalence of isolated antibody to hepatitis B core antigen in an area endemic for hepatitis B virus infection: Implication in hepatitis B vaccination programs. Hepatology 1988;8:766-770 
  9. Oh MK, Kim JS, Lee YB, Han JH. Seroprevalence of hepatitis B virus markers among adult in a Yungdong area of Kwangwon province. J Korean Acad Fam Med 2000; 21(1): 91-99 (Korean) 
  10. Yoo K, Lee HS, Kim CY. Detection of HBV DNA in patients with chronic liver disease with Isolated antibody to HBcAg using the polymerase chain reaction. Korean J Gastroenterol 1991; 23: 469-474 (Korean) 
  11. Silva AE, McMahon BJ, Parkinson AJ, Sjogren MH, Hoofnagle JH, Di Bisceglie AM. Hepatitis B virus DNA in persons with isolated antibody to hepatitis B core antigen who subsequently received hepatitis B vaccine, Clin Infect Dis 1995; 26:8 95-97 
  12. McMahon BJ, Parkinson AJ, Helminiak C, Wainwright RB, Bulkow L, Kellerman-Douglas A, Schoenberg S. Ritter D. Response to hepatitis B vaccine of persons positive for antibody to hepatitis B core antigen. Gastroenterology 1992; 103(2): 590-594 
  13. Draelos M. Morgan T, Schifman RB, Sampliner RE. Signiticance of isolated antibody to hepatitis B core antigen determined by immune response to hepatitis B vaccinatlon. JAMA 1987; 258(9): 1193-1195 
  14. Sunbul M, Leblebicioglu H, Esen S, Eroglu C, Barut S. Response to hepatitis B vaccine in HBsAg/anti-HBs negative and anti-HBc positive subjects Scand. J lnfect Dis 2000; 32: 315-316 
  15. Ural O, Findik D. The response of isolated anti-HBc positive subjects to recombinant hepatitis B vaccine. J Infect 2001;43: 187-190 
  16. General recommendations of vaccination. Ministry of Health and Welfare, Advisory Committee on Vaccination 1998 
  17. B. Duval, N. Boulianne, G. De Serres. P, De Walis P, Masse R, Trudeau G, Delage G, Desjardins L, Salary A. Should children with isolated anti-HBs or ani-HBc be immunized against hepatitis B virus? JAMA 1997; 278: 1064 
  18. Zuckerman JN, Zuckerman AJ. Current topics in hepatitis B. J Infect 2000; 41: 130-6 
  19. Mosley JW, Stevens CE, Aach RD, Hollinger FB, Mimms LT, Solomon LR. Barbosa LH, Nemo GJ. Donor screenig for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipients. Transfusion 1995: 35: 5-12 
  20. Dickson RC, Everhart JE, Lake JR, Wei Y, Seaberg EC, Wiesner RH, Zetterman RK, Pruett TL, lshitani MB, Hoofnagle JH. Transmission of hepatitis B by transplantstion of livers from donors positive for antibody to hepatitis B core antigen. The national institute of diabetes and digestive and kidney diseases liver transplantation database. Gastroenterology 1997: 113: 1668-1674 
  21. Andre FE. Summary of safety and efficacy data on a yeast-derived hepatitis B vaccine. Am J Med 1989; 87: 14S-20S 
  22. Davidson M, Krugman S. Recombinant yeast hepatitis B vaccine compared with plasma-derived vaccine: immunogenicity and effect of a booster dose. J Infect 1986: 13: 31-38 
  23. Wu JS, Chen CH, Chiang YH, Lee YC, Lee MH, Ko YC, Hu HT. Hepatitis B virus infection in Taiwan with reference 10 anti-HBc versus HBsAg and anti-HBs. J Formosan Med Assoc 1980: 79: 760-767 
  24. Khalid A. Al-Mekhaizeem, Michael Miriello and Averell H, Sherker. The frequency and significance of isolated hepatitis B core antibody and the suggested management of patients, Can Med Assoc J 2001; 165: 1063-1064 
  25. Lai CL, Lau JYN, Yeoh EK, Chang WK, Lin HJ. Significance of isolated anti-HBc sempositivity by ELISA: Implications and the role of radioimmunoassay. J Med Virol 1992: 36: 180-183 
  26. Parkinson AJ, McMahon BJ, Hall D, Ritter D, Fitzgerald MA. Comparison of enzyme imnunoassay with radioimnunoassay tor the detection of antibody to hepatitis B core antigen as the only marker of hepatitis B infection in a population with a high prevalence of hepatitis B. J Med Virol 1990; 30: 253-257 
  27. Chan CY, Lee SD, Tsai YT. Lo KJ. Hepatitis H vaccination alone IS not adequate for the categolizing of adult subjects with isolated anti-HBc. J Gastroenterol Hepatol 1995: 10: 192-197 
  28. Hofer M, Joller-Jemelka HI, Grab PJ, Luthy R, Opravil M, Frequent chronic hepatitis 13 virus infection in HIV infected patient, positive for antibody to hepatitis B core antigen only. Eur J Clin Microbiol Infect Dis 1998: 17: 6-13 
  29. Ljunggren KK, Norbengelt E, Kidd A Correlation of HBeAg/anti-HBe, ALT levels, and HBV DNA PCR results in HBsAg-positive patients, J Med Virol 1993: 39(4): 297-302 
  30. Brechot C, Dcgos F, Lugassy C, Thiers V, Zafrani S, Franco D, Bismuth H, Trepo C, Benhamou JP, Wands J, Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen, N Engl J Med 1985; 31: 270-276 
  31. Rumi M, Colombo M, Romeo A. Boschini A. Zanetti A. Gringeri A, Mannucci PM, Suboptimal response to hepatitis B vaccine in drug users, Arch. lntern Med 1991: 151: 574-578 
  32. McMahon BJ, Bender TR, Berquist KR. Schreeder MT, Harpster AP. Delayed development of antibody to hepatitis B surtace antigen after symptomatic infection with hepatitis B virus, J Clin Microhiol 1981 14: 130-134 
  33. The annual report of health promotion center, Aasan Medical Center. the seventh edition, 2003 
  34. Yoo KY, Park BJ, Ahn YO. Seroepidemiology of Hepatitis B Virus Infection in healthy Korean adults in Seoul. Korean J Prev Med 1988 21; 1:89-98(Korean) 
  35. Kara IH, Yilmaz ME, Suner A, Kadiroglu AK. lsikoglu B, The evaluation of immune responses that occur after HBV infection and HBV vaccination in hemodialysis patients, Vaccine 2004 28(22); 22: 3963-3967 

이 논문을 인용한 문헌 (0)

  1. 이 논문을 인용한 문헌 없음

원문보기

원문 PDF 다운로드

  • ScienceON :
  • KCI :

원문 URL 링크

원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다. (원문복사서비스 안내 바로 가기)

상세조회 0건 원문조회 0건

DOI 인용 스타일